Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Goodwill & Intangibles (2021 - 2024)

Historic Goodwill & Intangibles for Core Scientific (CORZ) over the last 4 years, with Q1 2024 value amounting to $2.1 million.

  • Core Scientific's Goodwill & Intangibles fell 133.95% to $2.1 million in Q1 2024 from the same period last year, while for Mar 2024 it was $2.1 million, marking a year-over-year decrease of 133.95%. This contributed to the annual value of $2.2 million for FY2023, which is 3186.62% up from last year.
  • Core Scientific's Goodwill & Intangibles amounted to $2.1 million in Q1 2024, which was down 133.95% from $2.2 million recorded in Q4 2023.
  • Core Scientific's 5-year Goodwill & Intangibles high stood at $1.1 billion for Q4 2021, and its period low was $1.4 million during Q3 2022.
  • For the 4-year period, Core Scientific's Goodwill & Intangibles averaged around $289.9 million, with its median value being $2.5 million (2023).
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first tumbled by 9984.05% in 2022, then surged by 7485.71% in 2023.
  • Over the past 4 years, Core Scientific's Goodwill & Intangibles (Quarter) stood at $1.1 billion in 2021, then crashed by 99.84% to $1.7 million in 2022, then soared by 31.87% to $2.2 million in 2023, then dropped by 4.94% to $2.1 million in 2024.
  • Its Goodwill & Intangibles stands at $2.1 million for Q1 2024, versus $2.2 million for Q4 2023 and $2.4 million for Q3 2023.